SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Sick Visit — Sun Yat-sen — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientSun Yat-sen
Date of birth1866-11-12
IdentifiersMRN HR-ET016-SYN-TD; SSN (made up) 000-16-4183
Document date1924-09-02
AuthorWen-Li Huang, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Sore throat, runny nose and cough for three days during chemotherapy. [S]

History of Present Illness

Mr. Sun called the clinic and was seen the same day. Three days ago he developed a scratchy throat and a runny nose after a week of meetings, and since yesterday a dry cough. He checked his temperature twice a day as taught and the highest was 37.5 °C; he has had no shivering. He is on day 10 of cycle 5 of gemcitabine, cisplatin and durvalumab and had his day-8 infusion two days ago. He is not short of breath, even on the stairs, and has no chest pain, diarrhea, rash, or new abdominal pain. His appetite is a little lower but he is drinking well. Two colleagues at work have colds. He asked whether this could be pneumonitis from durvalumab and whether he needs antibiotics. [S]

ElementDetail
OnsetThree days ago, after colleagues at work had colds
SymptomsSore throat, runny nose, dry cough
TemperatureHighest 37.5 °C at home; no shivering
Treatment contextDay 10 of cycle 5 of gemcitabine, cisplatin and durvalumab; day-8 dose two days ago
Associated signs and symptomsNo breathlessness, chest pain, diarrhea, rash, or new abdominal pain
Modifying factorsWarm drinks and honey help the throat

Review of Systems

SystemResultFinding
ConstitutionalPositiveTired; no fever above 37.5 °C; no shivering
Ears, nose, mouth, and throatPositiveSore throat and runny nose; no mouth ulcers
RespiratoryPositiveDry cough; no breathlessness or sputum
CardiovascularNegativeNo chest pain or palpitations
GastrointestinalNegativeNo diarrhea, vomiting, or new abdominal pain
IntegumentaryNegativeNo rash; port site not sore

6 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Acetaminophen 500 mg oral tablet, two tablets by mouth every 8 hours as needed for right upper abdominal ache; no more than 3,000 mg a dayTwo tablets by mouth every 8 hours as needed, no more than 3,000 mg a dayOral route1924-05-04activeS
Gemcitabine 1,000 mg/m2 (1,660 mg) intravenous infusion on days 1 and 8 of each 21-day cycleDays 1 and 8 of each 21-day cycle, up to 8 cyclesIntravenous route1924-06-01activeS
Cisplatin 25 mg/m2 (41 mg) intravenous infusion on days 1 and 8 of each 21-day cycleDays 1 and 8 of each 21-day cycle, up to 8 cycles, with hydrationIntravenous route1924-06-01activeS
Durvalumab 1,500 mg intravenous infusion on day 1 of each 21-day cycleDay 1 of each 21-day cycle with chemotherapy, then every 4 weeks aloneIntravenous route1924-06-01activeS
Ondansetron 8 mg oral tablet, one tablet by mouth every 8 hours as needed for nauseaOne tablet by mouth every 8 hours as needed for nauseaOral route1924-06-01activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1924-09-02Body height165cmS
1924-09-02Body weight59kgS
1924-09-02Body mass index (BMI) [Ratio]21.7kg/m2S
1924-09-02Systolic blood pressure120mm[Hg]S
1924-09-02Diastolic blood pressure76mm[Hg]S
1924-09-02Heart rate90/minS
1924-09-02Respiratory rate16/minS
1924-09-02Body temperature37.4CelS
1924-09-02Oxygen saturation in Arterial blood by Pulse oximetry97%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1924-09-02Leukocytes [#/volume] in Blood by Automated count3.910*3/uL4-11 10*3/uLLowS
1924-09-02Neutrophils [#/volume] in Blood by Automated count1.610*3/uL1.8-7.7 10*3/uLLowS
1924-09-02Hemoglobin [Mass/volume] in Blood10.6g/dL13.2-17.1 g/dLLowS
1924-09-02Platelets [#/volume] in Blood by Automated count16210*3/uL150-400 10*3/uLNormalS

Physical Exam

Vital signs recorded on 1924-09-02; see the Vital Signs section. [S]

SystemFinding
GeneralTired but well; temperature 37.4 °C, pulse 90, blood pressure 120/76, oxygen saturation 97% on room air, respirations 16
Ears, nose, mouth, and throatRed throat without exudate; no mouth ulcers or thrush; clear nasal discharge
NeckNo tender or enlarged lymph nodes
RespiratoryClear to auscultation bilaterally; no crackles or wheeze; oxygen saturation stays at 97% after walking the corridor
SkinPort site clean, without redness or tenderness; no rash

Problems

ProblemClinical statusVerificationCodeProvenance
Right upper quadrant abdominal mass with weight loss: a dull ache under the right ribs and early fullness for about three months, 4 kg weight loss, and a firm, non-tender mass felt 4 cm below the right costal margin; no jaundice, fever, or itching. Ultrasound today: a 6.8 cm solid, heterogeneous mass in liver segments IV and V that cannot be separated from the gallbladder, which contains stones; the rest of the liver is smooth, with no ascites. Multiphase CT, tumor markers, hepatitis serology and medical oncology consultation arrangedresolvedconfirmed R19.01S — Synthetic presenting problem anchored to the documented right upper abdominal mass; superseded by the biopsy diagnosis.
Adenocarcinoma of the gallbladder invading the liver: core biopsy of the liver mass shows moderately differentiated adenocarcinoma (CK7 positive, CK20 and CDX2 negative), and multiphase CT and MRI show a 7.1 cm mass arising from the gallbladder fundus and invading liver segments IVb and V, with gallstones and two enlarged nodes in the hepatoduodenal ligament; no cirrhosis; alpha-fetoprotein normal, CA 19-9 raised. Clinical T3 N1 before staging laparoscopy (AJCC 8th edition). Synthetic modern episode linked to his documented final illness, described in life as liver cancer and at autopsy as gallbladder adenocarcinomaactiveconfirmed C23S — Synthetic modern diagnosis chosen to fit the documented findings: a mass involving the liver at operation and gallbladder adenocarcinoma at autopsy.
Resolved hepatitis B infection: hepatitis B surface antigen negative, total core antibody positive, surface antibody positive, HBV DNA undetectable; hepatitis C antibody negative. At risk of reactivation during chemotherapy and immunotherapy; monitoredactiveconfirmed Z86.19S — Synthetic serology; not a claim that he had hepatitis B in his lifetime. No fetched source mentions hepatitis.
Peritoneal metastases from gallbladder adenocarcinoma: several 3 to 6 mm nodules on the parietal peritoneum and omentum at staging laparoscopy, biopsy positive for adenocarcinoma of the same type; stage IVB (M1), not resectableactiveconfirmed C78.6S — Synthetic finding anchored to the peritoneal metastases reported at autopsy.
Acute viral upper respiratory infection on day 10 of cycle 5 of chemoimmunotherapy: sore throat, runny nose and dry cough for three days, afebrile, with a neutrophil count of 1.6 x10^3/uL; rapid tests for SARS-CoV-2 and influenza negative; no sign of pneumonia or pneumonitis; resolvedactiveconfirmed J06.9S — Synthetic acute illness; not a historical claim.

Assessment and Plan

Guideline basis: NCCN Clinical Practice Guidelines in Oncology: Biliary Tract Cancers (2026); Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update (2021); Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update (2018)

Follow-up: Phone check in two days. Cycle 6 day 1 as booked, with the oncology team; preventive visit in about three weeks. Next scheduled visit 1924-09-21: periodic adult preventive visit. [S]